[{"_id":"551f899531cae9239deb1aaa","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2014年5月期","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","__v":0,"日付":"2015-04-04T06:49:57.897Z"},{"_id":"551f899531cae9239deb1aab","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2013年5月期","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","__v":0,"日付":"2015-04-04T06:49:57.897Z"},{"_id":"551f899531cae9239deb1aad","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2014年5月期","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","__v":0,"日付":"2015-04-04T06:49:57.899Z"},{"_id":"551f899531cae9239deb1ab0","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2014年5月期","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","__v":0,"日付":"2015-04-04T06:49:57.901Z"},{"_id":"551f899531cae9239deb1aaf","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年7月13日","決算月数":"12か月","売上高":"279,021百万円","営業利益":"13,329百万円","経常利益":"14,517百万円","当期利益":"7,737百万円","EPS（一株当たり利益）":"390.78円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,837.41円","総資産":"99,469百万円","自己資本":"36,380百万円","資本金":"4,178百万円","有利子負債":"2,929百万円","自己資本比率":"36.6%","ROA（総資産利益率）":"8.43%","ROE（自己資本利益率）":"23.42%","総資産経常利益率":"15.83%","__v":0,"日付":"2015-04-04T06:49:57.900Z"},{"_id":"551f899531cae9239deb1ab2","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年7月13日","決算月数":"12か月","売上高":"279,021百万円","営業利益":"13,329百万円","経常利益":"14,517百万円","当期利益":"7,737百万円","EPS（一株当たり利益）":"390.78円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,837.41円","総資産":"99,469百万円","自己資本":"36,380百万円","資本金":"4,178百万円","有利子負債":"2,929百万円","自己資本比率":"36.6%","ROA（総資産利益率）":"8.43%","ROE（自己資本利益率）":"23.42%","総資産経常利益率":"15.83%","__v":0,"日付":"2015-04-04T06:49:57.902Z"},{"_id":"551f899531cae9239deb1aac","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年7月13日","決算月数":"12か月","売上高":"279,021百万円","営業利益":"13,329百万円","経常利益":"14,517百万円","当期利益":"7,737百万円","EPS（一株当たり利益）":"390.78円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,837.41円","総資産":"99,469百万円","自己資本":"36,380百万円","資本金":"4,178百万円","有利子負債":"2,929百万円","自己資本比率":"36.6%","ROA（総資産利益率）":"8.43%","ROE（自己資本利益率）":"23.42%","総資産経常利益率":"15.83%","__v":0,"日付":"2015-04-04T06:49:57.897Z"},{"_id":"551f899531cae9239deb1ab1","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2013年5月期","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","__v":0,"日付":"2015-04-04T06:49:57.901Z"},{"_id":"551f899531cae9239deb1aae","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2013年5月期","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","__v":0,"日付":"2015-04-04T06:49:57.899Z"},{"_id":"551f899531cae9239deb1ab3","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2014年5月期","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","__v":0,"日付":"2015-04-04T06:49:57.903Z"},{"_id":"551f899531cae9239deb1ab4","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2013年5月期","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","__v":0,"日付":"2015-04-04T06:49:57.904Z"},{"_id":"551f899531cae9239deb1ab5","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年7月13日","決算月数":"12か月","売上高":"279,021百万円","営業利益":"13,329百万円","経常利益":"14,517百万円","当期利益":"7,737百万円","EPS（一株当たり利益）":"390.78円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,837.41円","総資産":"99,469百万円","自己資本":"36,380百万円","資本金":"4,178百万円","有利子負債":"2,929百万円","自己資本比率":"36.6%","ROA（総資産利益率）":"8.43%","ROE（自己資本利益率）":"23.42%","総資産経常利益率":"15.83%","__v":0,"日付":"2015-04-04T06:49:57.904Z"},{"_id":"55200a2db6241657bb271008","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2014年5月期","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","__v":0,"日付":"2015-04-04T15:58:37.251Z"},{"_id":"55200a2db6241657bb271009","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2013年5月期","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","__v":0,"日付":"2015-04-04T15:58:37.251Z"},{"_id":"55200a2db6241657bb27100a","会社名":"(株)コスモス薬品【3349】","証券コード":"3349","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年7月13日","決算月数":"12か月","売上高":"279,021百万円","営業利益":"13,329百万円","経常利益":"14,517百万円","当期利益":"7,737百万円","EPS（一株当たり利益）":"390.78円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,837.41円","総資産":"99,469百万円","自己資本":"36,380百万円","資本金":"4,178百万円","有利子負債":"2,929百万円","自己資本比率":"36.6%","ROA（総資産利益率）":"8.43%","ROE（自己資本利益率）":"23.42%","総資産経常利益率":"15.83%","__v":0,"日付":"2015-04-04T15:58:37.251Z"}]